- NOK1.41bn
- NOK1.10bn
- NOK243.98m
- 84
- 13
- 76
- 62
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 53.84 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.5 | ||
Price to Tang. Book | 4.34 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 5.34 | ||
EV to EBITDA | 50.79 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -3.76% | ||
Return on Equity | -0.79% | ||
Operating Margin | -14.06% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | NOKm | 47.93 | 70.58 | 137.13 | 195.26 | 243.98 | 280 | 364.5 | 59.06% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +340.56 | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Carasent ASA is a Norway-based technology Company. The strategy of Carasent is to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. The Company provides its customers with cloud based medical record software solutions and a broad ecosystem of integrated services, in a range of healthcare segments. Carasent focuses on businesses that develop entrepreneurial and e-health solutions. Operating business activities in the Group can be categorized into six different categories; Software as a Service (SaaS), Add-on services, Consulting, License, maintenance and other. All services are delivered to the health care sector.
Directors
- Leif Lindqvist CHM
- Dennis Hojer CEO
- Shane Smith SVP
- Christopher Damvakaris VBD
- Thomas Tighe OTH
- Ebba Fahraeus DRC (58)
- Terje Rogne DRC
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- October 9th, 2001
- Public Since
- April 8th, 2002
- No. of Employees
- 169
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Oslo Stock Exchange
- Shares in Issue
- 72,324,781

- Address
- c/o Advokatsenteret AS, BILLINGSTAD, 0164
- Web
- https://carasent.com/
- Phone
- +1 7038902800
- Auditors
- KPMG AS
Upcoming Events for CARA
Carasent ASA Annual Shareholders Meeting
Q1 2025 Carasent ASA Earnings Release
Similar to CARA
5Th Planet Games A/S
Oslo Stock Exchange
Atea ASA
Oslo Stock Exchange
Ayfie International AS
Oslo Stock Exchange
Bouvet ASA
Oslo Stock Exchange
Crayon Holding ASA
Oslo Stock Exchange
FAQ
As of Today at 18:47 UTC, shares in Carasent ASA are trading at NOK19.55. This share price information is delayed by 15 minutes.
Shares in Carasent ASA last closed at NOK19.55 and the price had moved by +98.08% over the past 365 days. In terms of relative price strength the Carasent ASA share price has outperformed the FTSE Global All Cap Index by +80.12% over the past year.
The overall consensus recommendation for Carasent ASA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCarasent ASA does not currently pay a dividend.
Carasent ASA does not currently pay a dividend.
Carasent ASA does not currently pay a dividend.
To buy shares in Carasent ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of NOK19.55, shares in Carasent ASA had a market capitalisation of NOK1.41bn.
Here are the trading details for Carasent ASA:
- Country of listing: Norway
- Exchange: OSL
- Ticker Symbol: CARA
Based on an overall assessment of its quality, value and momentum Carasent ASA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Carasent ASA is NOK26.75. That is 36.83% above the last closing price of NOK19.55.
Analysts covering Carasent ASA currently have a consensus Earnings Per Share (EPS) forecast of -NOK0.11 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carasent ASA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +13.35%.
As of the last closing price of NOK19.55, shares in Carasent ASA were trading +17.99% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Carasent ASA PE ratio based on its reported earnings over the past 12 months is 53.84. The shares last closed at NOK19.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Carasent ASA's management team is headed by:
- Leif Lindqvist - CHM
- Dennis Hojer - CEO
- Shane Smith - SVP
- Christopher Damvakaris - VBD
- Thomas Tighe - OTH
- Ebba Fahraeus - DRC
- Terje Rogne - DRC